Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Dec;86(6):2099-108.
doi: 10.1172/JCI114948.

Phenotypic and functional characterization of T cells from patients with myasthenia gravis

Affiliations

Phenotypic and functional characterization of T cells from patients with myasthenia gravis

F Mokhtarian et al. J Clin Invest. 1990 Dec.

Abstract

A study of cell surface phenotypes of PBL of myasthenia gravis (MG) patients showed that their T cells had a significantly higher percentage of 4B4+ T cells (the helper/inducer subset) than age- and sex-matched controls. The PBL of MG patients proliferated significantly higher than those of normal subjects (NS) in response to the purified alpha chain of the acetylcholine receptor (AChR). Anti-AChR antibody was present in sera of 88% of MG and none of the NS. The PBL B cells from MG only, when cultured with autologous T cells and stimulated with either pokeweed mitogen (69%), or AChR-alpha chain (38%), secreted antibody to AChR-alpha chain, whereas T and B cells alone secreted no antibody. T cells from PBL of MG patients were more readily cloned than T cells of NS, by limiting dilution, in the presence of recombinant IL-2 and in the absence of AChR-alpha chain. About 50% of T cell clones from MG patients, compared to none from NS, proliferated to AChR-alpha chain. This response was HLA-DR restricted. MG T cell clones did not display significant cytotoxic activity, as compared to control T cell clones. Our results indicate that in MG, 4B4+ regulatory T cells play their role in the pathogenesis of MG, not by cytotoxicity, but more likely by their ability to stimulate specific antibody production by B cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. J Immunol. 1989 Jul 15;143(2):633-7 - PubMed
    1. N Engl J Med. 1976 Mar 25;294(13):694-8 - PubMed
    1. J Exp Med. 1976 Sep 1;144(3):739-53 - PubMed
    1. Clin Immunol Immunopathol. 1977 Jan;7(1):36-43 - PubMed

Publication types

MeSH terms